BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Morton RP, Stell PM, Derrick PPO. Epidemiology of cancer of the middle ear cleft. Cancer 1984;53:1612-7. [DOI: 10.1002/1097-0142(19840401)53:7<1612::aid-cncr2820530733>3.0.co;2-p] [Cited by in Crossref: 46] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Surono A, Hariwiyanto B, Samodra E. Detection of Epstein-Barr and Human Papilloma Viruses in the Middle Ear Squamous Cell Carcinoma. Indian J Otolaryngol Head Neck Surg 2018;70:66-70. [PMID: 29456946 DOI: 10.1007/s12070-016-0991-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
2 Acharya SP, Pathak C, Giri S, Bista M, Mandal D. Left Chronic Otitis Media with Squamous Cell Carcinoma of the Middle Ear and Postauricular Mastoid Fistula: A Case Report. JNMA J Nepal Med Assoc 2020;58:341-4. [PMID: 32538931 DOI: 10.31729/jnma.4954] [Reference Citation Analysis]
3 Nagano T, Yoshimura RI, Kojima M, Nakagawa K, Toda K. Outcomes of radiotherapy in advanced external auditory canal cancer. J Radiat Res 2019;60:380-6. [PMID: 31116854 DOI: 10.1093/jrr/rrz010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ungar OJ, Santos F, Nadol JB, Horowitz G, Fliss DM, Faquin WC, Handzel O. Invasion Patterns of External Auditory Canal Squamous Cell Carcinoma: A Histopathology Study. Laryngoscope 2021;131:E590-7. [PMID: 32311775 DOI: 10.1002/lary.28676] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Miyazaki M, Aoki M, Okado Y, Koga K, Hamasaki M, Kiyomi F, Sakata T, Nakagawa T, Nabeshima K. Poorly Differentiated Clusters Predict a Poor Prognosis for External Auditory Canal Carcinoma. Head Neck Pathol 2019;13:198-207. [PMID: 29846906 DOI: 10.1007/s12105-018-0939-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
6 Shinomiya H, Uehara N, Fujita T, Miyawaki D, Imamura Y, Teshima M, Kakigi A, Kiyota N, Sasaki R, Nibu KI. Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF-CRT) for locally advanced squamous cell carcinoma of the external auditory canal. Eur Arch Otorhinolaryngol 2021. [PMID: 34263358 DOI: 10.1007/s00405-021-06974-4] [Reference Citation Analysis]
7 Nabuurs CH, Kievit W, Labbé N, Leemans CR, Smit CFGM, van den Brekel MWM, Pauw RJ, van der Laan BFAM, Jansen JC, Lacko M, Braunius WW, Morita S, Wierzbicka M, Matoba T, Hanai N, Takes RP, Kunst HPM. Evaluation of the modified Pittsburgh classification for predicting the disease-free survival outcome of squamous cell carcinoma of the external auditory canal. Head Neck 2020;42:3609-22. [PMID: 32794253 DOI: 10.1002/hed.26424] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
8 Hayashi K, Koto M, Demizu Y, Saitoh JI, Suefuji H, Okimoto T, Ohno T, Shioyama Y, Takagi R, Ikawa H, Nemoto K, Nakano T, Kamada T. A retrospective multicenter study of carbon-ion radiotherapy for external auditory canal and middle ear carcinomas. Cancer Med 2019;8:51-7. [PMID: 30548207 DOI: 10.1002/cam4.1830] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]